Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for ...
Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make ...
As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...
The holding companies have broadly denied wrongdoing in a suit they filed against the FTC last November in the U.S. District Court for the Eastern District of Missouri. The PBM's 41-page lawsuit ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report (Second Report) stemming from its investigation into pharmacy benefit ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs.
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
during his first term the FTC allowed consolidation to occur in the industry in the late 2010s. And despite the anti-PBM rhetoric in Trump’s White House, practically nothing of substance was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results